BioSpace News Archive

Compass Therapeutics, Inc. announced that the Company will participate in a fireside chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference taking place in New York City, NY on May 20, 2024.

IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform, today reported financial results for the first quarter ended March 31, 2024.

ZyVersa Therapeutics, Inc. announces that Stephen C. Glover, Co-Founder, Chairman, Chief Executive Officer, and President, will participate in the 2024 BIO International Convention being held June 3 - 6, 2024 in San Diego, California.

Revolo Biotherapeutics announced that it will present at two medical meetings in May: The American Thoracic Society 2024 International Conference and the 6th Treg Directed Therapies Summit.

Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, announced that the Company will participate in two upcoming investor conferences in May 2024.

Ovid Therapeutics Inc., a biopharmaceutical company dedicated to meaningfully improving the lives of people affected by rare epilepsies and brain conditions, reported business updates and financial results for the first quarter ended March 31, 2024.

Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced financial results for the first quarter of 2024 and provided a corporate update.

Provectus Biopharmaceuticals, Inc. were presented at the annual meeting of the Association for Research in Vision and Ophthalmology (“ARVO”), held May 5-9, 2024 in Seattle, Washington.

Belite Bio, Inc. today announced that the executive management team will participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference being held virtually on May 21 and 22, 2024.

Palisade Bio, Inc. today reported its financial results for the first quarter 2024 and provided a business update.